December 8, 2019 – December 12, 2019
Recent Posts
- VYLUMA COMPLETES LAST PATIENT VISIT FOR PRIMARY ANALYSIS OF PIVOTAL PHASE III CHAMP STUDY EVALUATING NVK002 FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN
- VYLUMA AND LABORATOIRES THÉA ENTER INTO LICENSING AGREEMENT FOR THE REGISTRATION AND COMMERCIALIZATION OF NVK002 IN CANADA, MEXICO, AND SELECT SOUTH AMERICAN COUNTRIES
- NEVAKAR INJECTABLES SELLS SIX DEVELOPMENT-STAGE, READY-TO-USE INJECTABLE PRODUCT CANDIDATES TO ENDO VENTURES LIMITED
- NEVAKAR INJECTABLES RECEIVES U.S. FDA APPROVAL OF READY-TO-USE EPHEDRINE INJECTION IN A PREFILLED SYRINGE
- Nevakar Injectables Announces the Launch of Ready-to-Use Ephedrine Injection Vials
Recent Comments